Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (5), Acute Rhinitis
...CenterWatch: New Medical Therapies in Disease Category (5), Acute Rhinitis Acute Rhinitis Patient Medical Areas • Immunology/Infectious Diseases • Otolaryngology March 23, 2009 Cydex released positive results from ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (692), Vasomotor Rhinitis
...CenterWatch: New Medical Therapies in Disease Category (692), Vasomotor Rhinitis Vasomotor Rhinitis Patient Medical Areas • Pulmonary/Respiratory Diseases December 5, 2005 Rigel Pharmaceuticals issued negative results of ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (804), Rhinitis, Allergic, Perennial
...CenterWatch: New Medical Therapies in Disease Category (804), Rhinitis, Allergic, Perennial Rhinitis, Allergic, Perennial Patient Medical Areas • Immunology/Infectious Diseases May 26, 2008 Allergy Therapeutics released positive ...
View Page

4.  CenterWatch: Clinical Trials in Category (804) Rhinitis, Allergic, Perennial
...CenterWatch: Clinical Trials in Category (804) Rhinitis, Allergic, Perennial Rhinitis, Allergic, Perennial State • Louisiana • Texas Louisiana Metairie : Clinical Research Specialists A one-year study to ...
View Page

5.  Newly Approved Drug Therapies (949) Veramyst (fluticasone furoate), GlaxoSmithKline,
...fluticasone furoate) Company: GlaxoSmithKline Approval Status: Approved April 2007 Treatment Area: seasonal and perennial allergic rhinitis General Information Veramyst is a nasal spray containing an aqueous suspension of micronized fluticasone furoate ...
...a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. The precise mechanism of action on rhinitis symptoms is not known. Veramyst is specifically indicated for the treatment of the symptoms of ...
View Page

6.  Newly Approved Drug Therapies (1058) Astepro (azelastine hydrochloride nasal spray), Meda Pharmaceuticals,
...spray) Company: Meda Pharmaceuticals Approval Status: Approved October 2008 Treatment Area: seasonal and perennial allergic rhinitis General Information Astepro is an H1-receptor antagonist indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis. It is administered via a metered dose nasal spray. Astepro Nasal Spray 0.1% and ...
View Page

7.  Newly Approved Drug Therapies (952) Xyzal (levocetirizine dihydrochloride), UCB,
...levocetirizine dihydrochloride) Company: UCB Approval Status: Approved May 2007 Treatment Area: seasonal and perennial allergic rhinitis and urticaria General Information The active component of Xyzal, Levocetirizine dihydrochloride, is an anti-histamine ...
...these H1 receptors. Xyzal is specifically indicated for the relief of symptoms associated with allergic rhinitis (seasonal and perennial) in adults and children 6 years of age and older. Xyzal is ...
View Page

8.  CenterWatch: Otolaryngology Approved Drug Therapies
...Astepro (azelastine hydrochloride nasal spray) ; Meda Pharmaceuticals; For the treatment of seasonal and perennial allergic rhinitis, Approved October 2008 Moxatag (amoxicillin) ; MiddleBrooke Pharmaceuticals; For the treatment of tonsillitis and/or pharyngitis ...
...and pediatrics, Approved January 2008 Patanase (olopatadine hydrochloride) ; Alcon; For the treatment of seasonal allergic rhinitis, Approved April 2008 Drugs Approved in 2007 Veramyst (fluticasone furoate) ; GlaxoSmithKline; For the treatment of ...
View Page

9.  Study Posting (1615) Trial #163113, Rhinitis, Allergic, Perennial, Dallas, TX
...Study Posting (1615) Trial #163113, Rhinitis, Allergic, Perennial, Dallas, TX Trial Information Do you have allergies? (all ages) Pharmaceutical Research & Consulting ...
...Inc. support@centerwatch.com judy.johns@daac-prc.com Do you have allergies? (all ages) Rhinitis, Allergic, Perennial Dallas, TX 163113 Clinical Trial Participation If you would like to learn more ...
View Page

10.  Study Posting (5402) Trial #156544, Rhinitis, Allergic, Perennial, Metairie, LA
...Study Posting (5402) Trial #156544, Rhinitis, Allergic, Perennial, Metairie, LA Trial Information A one-year study to evaluate fluticasone nasal spray ...
...fluticasone nasal spray once daily on growth in pediatric subjects with perennial (year round) rhinits. Rhinitis, Allergic, Perennial Metairie, LA 156544 Clinical Trial Participation If you would like to learn more ...
View Page

11.  Newly Approved Drug Therapies (747) Clarinex, Schering-Plough,
...presentations. Drug Name: Clarinex Company: Schering-Plough Approval Status: Approved February 2002 Treatment Area: Allergic rhinitis; Chronic ideopathic urticaria General Information Clarinex, in an oral tablet formulation, was approved for the treatment of seasonal allergic rhinitis (SAR)in adults and children over 12 years of age in December 2001. In February ...
View Page

12.  Study Posting (367) Trial #59677, Allergy (Pediatric), Louisville, KY
...Study Posting (367) Trial #59677, Allergy (Pediatric), Louisville, KY Trial Information Pediatric Perennial Allergic Rhinitis (PAR) Study. Eligibility Criteria: • Ages 2 - 5. • Must have 1-year history of PAR with ...
...Family Allergy and Asthma Research Institute support@centerwatch.com phall@familyallergy.com Pediatric Perennial Allergic Rhinitis (PAR) Study. Allergy (Pediatric) Louisville, KY 59677 Clinical Trial Participation If you would like to ...
View Page

13.  Study Posting (5441) Trial #160118, Allergy, Overland Park, KS
...as a nasal aerosol, in adult and adolescent subjects (12 years & older) with Perennial Allergic Rhinitis. Subjects will be screened for a history of perennial allergic rhinitis (sneezing, nasal itch, runny nose, and nasal obstruction & congestion) for a minimum of 2 years ...
View Page

14.  Newly Approved Drug Therapies (604) Tri-Nasal Spray (triamcinolone acetonide spray), Muro Pharmaceutical,
...Spray (triamcinolone acetonide spray) Company: Muro Pharmaceutical Approval Status: Approved February 2000 Treatment Area: Allergic rhinitis General Information Tri-Nasal Spray, administered intranasally, has been approved for the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in adults & children 12 years of age or older. These symptoms include sneezing, stuffiness, discharge ...
View Page

15.  CenterWatch New Medical Therapies™ in Immunology/Infectious Diseases
...CenterWatch New Medical Therapies™ in Immunology/Infectious Diseases Immunology/Infectious Diseases Acute Rhinitis AIDS and AIDS related infections Allergies & Asthma Allergy Atopic Dermatitis Bacterial Infections Candidemia/Candidiasis Canker ...
...Heart Attack) Onychomycosis (Toenail Fungus) Oral Candidiasis Pneumonia Postherpetic Neuralgia Respiratory Syncytial Virus (RSV) Infection Rhinitis, Allergic, Perennial Sepsis and Septicemia Sexually Transmitted Diseases (STDs) Shingles Sjogren's Syndrome Smallpox Staphylococcal ...
View Page

16.  Study Posting (5441) Trial #160117, Allergies & Asthma, Overland Park, KS
...as a nasal aerosol, in adult and adolescent subjects (12 years & older) with Perennial Allergic Rhinitis. Subjects will be screened for a history of perennial allergic rhinitis (sneezing, nasal itch, runny nose, and nasal obstruction & congestion) for a minimum of 2 years ...
View Page

17.  Newly Approved Drug Therapies (982) Patanase (olopatadine hydrochloride), Alcon,
...Name: Patanase (olopatadine hydrochloride) Company: Alcon Approval Status: Approved April 2008 Treatment Area: seasonal allergic rhinitis General Information Patanase is an antihistamine with selective H1 -receptor antagonist activity: its principal effects ...
...H1 receptors. Patanase is specifically indicated for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. Patanase is supplied as a metered-dose ...
View Page

18.  CenterWatch New Medical Therapies™ in Otolaryngology
...CenterWatch New Medical Therapies™ in Otolaryngology Otolaryngology Acute Rhinitis Allergies & Asthma Allergy Aspergillosis Auditory Loss and Deafness Esophageal Cancer Oral Candidiasis Otitis Media Pharyngitis ...
View Page

19.  CenterWatch Clinical Research Profile (2144) Trial #1031, Allergy Diagnostics, San Antonio, TX
...testing. Our focus is on the care of the adult with Seasonal and Perennial Allergic Rhinitis. Background Six Board-Certified Pulmonologists and Internal medicine Specialists founded Allergy Diagnostics in 2002. The ...
...Quintiles • Research Point • TKL Research Our center specializes in clinical trials for: • Abdominal Pain • Allergic Rhinitis • Allergy Medications • Antibiotics • Antihistamines • Antihypertensives • Asthma • BCP’s • Bronchodilators • Cholesterol • COPD • Complicated Hypertension • Diabetes • Diagnosis ...
View Page

20.  Newly Approved Drug Therapies (137) Vancenase AQ 84 mcg Double Strength, Schering-Plough,
...Strength Company: Schering-Plough Approval Status: Approved June 1996 Treatment Area: allergic and non-allergic rhinitis General Information Vancenase AQ 84 mcg Double Strength, a once-daily aqueous corticosteroid nasal spray ...
...Double Strength is indicated for the relief of symptoms of allergic and non-allergic (vasomotor) rhinitis, including sneezing, runny nose, and nasal congestion. Vancenase AQ 84 mcg Double Strength is a ...
View Page